Vaginal ring
AssigneeSchering Corporation
InventorsGisela Schopflin, Gerhard Laudahn, Barbara Muhe, Heidemarie Hartmann, Fred Windt
Life of this patent
Estimating the term…
Loading patent…
AssigneeSchering Corporation
InventorsGisela Schopflin, Gerhard Laudahn, Barbara Muhe, Heidemarie Hartmann, Fred Windt
Estimating the term…
A composite vaginal ring containing a safe and effective amount of a pharmaceutically active medicament, which comprises: (a) a major supporting vaginal ring consisting essentially of a physiologically acceptable synthetic resin and having at least a portion of the annular surface thereof adapted to mate with corresponding minor, medicament-containing vaginal ring segment; and (b) at least one minor, medicament-containing vaginal ring segment adapted to mate with the modified annular surface of said major supporting vaginal ring and consisting essentially of a safe and effective amount of a pharmaceutically active amount of a nonionic, lipophilic drug dissolved or uniformly suspended in an elastomeric, cross-linked LTV linear dimethylpolysiloxane resin.
A composite vaginal ring containing a safe and effective amount of a pharmaceutically active medicament, consisting essentially of:
A vaginal ring according to claim 8, wherein said drug is at least one steroid hormone having progestational or estrogenic activity.
A vaginal ring according to claim 10, wherein said major supporting ring is composed of an elastomeric, cross-linked LTV linear dimethylpolysiloxane resin.
Dependencies are inferred from the claim text.